DesignMedix
Portland
About DesignMedix
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases. Its drugs are developed by covalently linking a chemical moiety derived from a resistance reversal agent in order to fulfill the roles of both therapeutic agent and resistance reversal agent, enabling medical practitioners to treat malaria and other infectious diseases without a hassle.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2017)
- Website: designmedix.com
- Phone: 503-688-1941
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/designmedix-143194 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.